Trials / Recruiting
RecruitingNCT04791098
Impact of Infectious Diseases Consultation on Vaccination Coverage Among People Waiting for a Kidney Transplant at the Clermont-Ferrand Hospital
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- University Hospital, Clermont-Ferrand · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Solid-organ transplant patients are at increased risk of infectious diseases. Among this population, infectious diseases may be life-threatening or lead to graft rejection. Their prevention is an important challenge. Despite specific national recommendations, vaccination is underutilized. That is why we propose a dedicated infectious diseases consultation during pre-kidney transplantation assessment.
Detailed description
The main objective of this study is to impove vaccine coverage before kidney transplantation. Enrollment was based on the waiting list for a kidney transplant. Patients newly listed are invited to participate by the transplant team (nephrology department) ; for those that are already registered, a notification letter is sent to their home. All patients included must : * complete a health questionnaire * take a blood test at day 0 : viral, bacterial and parasitic serologies, QuantiFERON-TB * take a chest X-ray and dental panoramic Patients randomized in interventional group will be seen in specific infectious diseases consultation at Clermont Ferrand Hospital. A letter of recommendations is sent to nephrologist for patients randomized in group control. The primary study endpoint (immunization coverage) is evaluated at 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Specific infectious diseases consultation | Specific infectious diseases consultation at Clermont Ferrand Hospital with a specialist doctor : * Update vaccinations * Advice to travelers * Diagnostic and treatment of latent tuberculosis infection |
Timeline
- Start date
- 2020-09-16
- Primary completion
- 2022-03-01
- Completion
- 2026-04-01
- First posted
- 2021-03-10
- Last updated
- 2021-03-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04791098. Inclusion in this directory is not an endorsement.